Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Aug 2013

Palomaki Glenn E, Melillo Stephanie, Marrone Michael, Douglas Michael P

Abstract excerpt

This evidence review addresses whether type 2 diabetes genomic risk panels improve health outcomes (e.g., reduce rates of developing type 2 diabetes) in low- or high-risk adults; two clinical scenarios promulgated by commercial companies offering such testing. Evidence for the analytic validity of available genomic profiles was inadequate. Clinical validity ranged from inadequate to convincing for 30 variants...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 2
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Meta-Analysis as Topic

Share to Reproducibility of Results

Share to Risk Assessment

Share to Transcription Factor 7-Like 2 Protein

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 23492876
DOI: 10.1038/gim.2013.8
PMCID: PMC4684162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review.PMID 23492876Read ↗

Recommendations from the EGAPP Working Group: does genomic profiling to assess type 2 diabetes risk improve health outcomes?Semantic proximity Read ↗

TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121,174 subjects.Semantic proximity Read ↗

Evaluation of risk prediction updates from commercial genome-wide scans.Semantic proximity Read ↗

Real-World Utility of GWAS-Based Diabetes Mellitus Panel Testing.Semantic proximity Read ↗

Is genetic testing useful to predict type 2 diabetes?Semantic proximity Read ↗

The transcription factor 7-like 2 (TCF7L2) gene is associated with Type 2 diabetes in UK community-based cases, but the risk allele frequency is reduced compared with UK cases selected for genetic studies.Semantic proximity Read ↗

Genetic risk profiling for prediction of type 2 diabetesSemantic proximity Read ↗

Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.Semantic proximity Read ↗

Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis.Semantic proximity Read ↗

TCF7L2 gene variants predispose to the development of type 2 diabetes mellitus among individuals with metabolic syndromeSemantic proximity Read ↗

The TCF7L2 diabetes risk variant is associated with HbA₁(C) levels: a genome-wide association meta-analysis.Semantic proximity Read ↗

Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.